+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Presbyopia - Epidemiology Forecast - 2032 - Product Thumbnail Image

Presbyopia - Epidemiology Forecast - 2032

  • Report
  • July 2022
  • 30 Pages
  • Global
From
From
From
From
Molluscum Contagiosum (MC) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Molluscum Contagiosum (MC) - Epidemiology Forecast - 2032

  • Report
  • June 2022
  • 52 Pages
  • Global
From
From
Bronchopulmonary Dysplasia - Epidemiology Forecast - 2032 - Product Thumbnail Image

Bronchopulmonary Dysplasia - Epidemiology Forecast - 2032

  • Drug Pipelines
  • March 2022
  • 62 Pages
  • Global
From
From
From
Treatment-resistant Hypertension (RHTN) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Treatment-resistant Hypertension (RHTN) - Epidemiology Forecast - 2032

  • Drug Pipelines
  • March 2022
  • 73 Pages
  • Global
From
Ankylosing Spondylitis (Bekhterev's Disease) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Ankylosing Spondylitis (Bekhterev's Disease) - Epidemiology Forecast - 2032

  • Drug Pipelines
  • February 2022
  • 105 Pages
  • Global
From
From
From
From
From
From
Primary Hyperoxaluria - Epidemiology Forecast - 2032 - Product Thumbnail Image

Primary Hyperoxaluria - Epidemiology Forecast - 2032

  • Drug Pipelines
  • February 2022
  • 76 Pages
  • Global
From
From
From
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more